CN Patent
CN1164574C — 苯氧基丙胺类化合物
Assigned to Tanabe Pharma Corp · Expires 2004-09-01 · 22y expired
What this patent protects
本发明涉及式(I)的苯氧基丙胺化合物、其旋光活性化合物或其药学可接受及其水合物:其中每个符号如说明书中定义,所述化合物对5-HT 1A 受体同时表现出选择性亲和力和拮抗活性,以及5-HT再摄取抑制活性,并且可以用作快速表达抗抑郁效应的抗抑郁药物。
USPTO Abstract
本发明涉及式(I)的苯氧基丙胺化合物、其旋光活性化合物或其药学可接受及其水合物:其中每个符号如说明书中定义,所述化合物对5-HT 1A 受体同时表现出选择性亲和力和拮抗活性,以及5-HT再摄取抑制活性,并且可以用作快速表达抗抑郁效应的抗抑郁药物。
Drugs covered by this patent
- Rexulti (BREXPIPRAZOLE) · Otsuka
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.